$IMRN exploding +41% AH 🚀 🔹 Immuron is a clinical-stage biopharma company focused on oral immunotherapy treatments targeting gut-mediated diseases and infecti

$IMRN exploding +41% AH 🚀 🔹 Immuron is a clinical-stage biopharma company focused on oral immunotherapy treatments targeting gut-mediated diseases and infectious illnesses 🧬 🔹 Lead programs include traveler's diarrhea and Campylobacter-related treatments with growing investor attention 🌍 🔹 Mas…